Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Brentuximab Vedotin + Chemotherapy for Hodgkin's Lymphoma
Recruiting2 awardsPhase 3
Louisville, Kentucky
This trial is studying brentuximab vedotin in combination with chemotherapy to see if it is more effective than chemotherapy alone in treating children with high risk Hodgkin lymphoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service